Business Description
Star Combo Pharma Ltd
ISIN : AU0000004798
Share Class Description:
ASX:S66: Ordinary SharesDescription
Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as Costar, Living Healthy, Amax, and J&K. It operates in two segments. The Star Combo segment engages in the development, manufacturing, marketing, and sales of natural health supplements and skincare products. The Austoyou retail business segment consists of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers, and Koala Mall's two retail stores in Sydney. Geographically, it operates in China and Australia.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.23 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | 0.55 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.24 | |||||
Beneish M-Score | -4.12 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.6 | |||||
3-Year EPS without NRI Growth Rate | 169.2 | |||||
3-Year Book Growth Rate | 2.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 78.23 | |||||
9-Day RSI | 62.95 | |||||
14-Day RSI | 53.61 | |||||
3-1 Month Momentum % | -38.64 | |||||
6-1 Month Momentum % | -43.75 | |||||
12-1 Month Momentum % | -27.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.64 | |||||
Quick Ratio | 5.63 | |||||
Cash Ratio | 4.92 | |||||
Days Inventory | 93.03 | |||||
Days Sales Outstanding | 34.26 | |||||
Days Payable | 80.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.85 | |||||
Dividend Payout Ratio | 0.1 | |||||
Forward Dividend Yield % | 2.85 | |||||
5-Year Yield-on-Cost % | 2.85 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 2.25 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 28.71 | |||||
Operating Margin % | -5.17 | |||||
Net Margin % | 22.44 | |||||
EBITDA Margin % | 32.89 | |||||
FCF Margin % | 25.17 | |||||
OCF Margin % | 27.34 | |||||
ROE % | 14.66 | |||||
ROA % | 11.64 | |||||
ROIC % | -4.78 | |||||
3-Year ROIIC % | 17.49 | |||||
ROC (Joel Greenblatt) % | 23.45 | |||||
ROCE % | 13.66 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 3.25 | |||||
PE Ratio without NRI | 3.25 | |||||
Price-to-Owner-Earnings | 4 | |||||
PS Ratio | 0.74 | |||||
PB Ratio | 0.46 | |||||
Price-to-Tangible-Book | 0.46 | |||||
Price-to-Free-Cash-Flow | 2.89 | |||||
Price-to-Operating-Cash-Flow | 2.71 | |||||
EV-to-EBIT | 0.68 | |||||
EV-to-EBITDA | 0.48 | |||||
EV-to-Revenue | 0.15 | |||||
EV-to-FCF | 0.41 | |||||
Price-to-GF-Value | 1 | |||||
Price-to-Projected-FCF | 1.86 | |||||
Price-to-Graham-Number | 0.26 | |||||
| Price-to-Net-Current-Asset-Value | 1.08 | |||||
| Price-to-Net-Cash | 1.86 | |||||
Earnings Yield (Greenblatt) % | 146.98 | |||||
FCF Yield % | 34.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Star Combo Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 23.995 | ||
| EPS (TTM) (A$) | 0.04 | ||
| Beta | 0.6285 | ||
| 3-Year Sharpe Ratio | 0.33 | ||
| 3-Year Sortino Ratio | 0.55 | ||
| Volatility % | 55.4 | ||
| 14-Day RSI | 53.61 | ||
| 14-Day ATR (A$) | 0.004336 | ||
| 20-Day SMA (A$) | 0.124 | ||
| 12-1 Month Momentum % | -27.03 | ||
| 52-Week Range (A$) | 0.11 - 0.275 | ||
| Shares Outstanding (Mil) | 135.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Star Combo Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Star Combo Pharma Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| AUD 0.003701 Cash Dividend | 2025-10-14 | 0.23 (-4.26%) | ||
| AUD 0.003701 Cash Dividend | 2024-10-14 | 0.16 (+0.00%) |
Show
Entries
Star Combo Pharma Ltd Frequently Asked Questions
What is Star Combo Pharma Ltd(ASX:S66)'s stock price today?
The current price of ASX:S66 is A$0.13. The 52 week high of ASX:S66 is A$0.28 and 52 week low is A$0.11.
When is next earnings date of Star Combo Pharma Ltd(ASX:S66)?
The next earnings date of Star Combo Pharma Ltd(ASX:S66) is .
Does Star Combo Pharma Ltd(ASX:S66) pay dividends? If so, how much?
The Dividend Yield %  of Star Combo Pharma Ltd(ASX:S66) is 2.85% (As of Today), Highest Dividend Payout Ratio of Star Combo Pharma Ltd(ASX:S66) was 0.1. The lowest was 0.1. And the median was 0.1. The  Forward Dividend Yield % of Star Combo Pharma Ltd(ASX:S66) is 2.85%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Star Combo Pharma Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers